CELYAD ONCOLOGY Stock Bearish Momentum With A 11% Fall At Session Start Today
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) slid by a staggering 11.76% to €0.75 at 10:11 EST on Thursday, after three sequential sessions in a row of losses. BEL 20 is rising 0.89% to €3,662.18, after five sequential sessions in a row of losses. This seems, up until now, a somewhat positive trend…